Champions Oncology, Inc. develops oncology drugs. The Company implants primary human tumors in immune-deficient mice and propagates the resulting engraftments such that the biological characteristics of the original human tumor are preserved. Champions Oncology then tests oncology drugs on the engraftments.
855 North Wolfe Street
Baltimore, MD 21205